417 results on '"Izumi, Takateru"'
Search Results
2. Basal interventricular septum thinning and long-term left ventricular function in patients with sarcoidosis
3. One-year lung function decline in sarcoidosis
4. Can the Sarcoidosis Health Questionnaire predict the long-term outcomes in Japanese sarcoidosis patients?
5. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies
6. Sarcoidosis-associated pulmonary hypertension and its treatment strategy
7. Pulmonary Angiitis and Granulomatosis
8. Clinical features of nodular-type muscle sarcoidosis
9. Interferon regulatory factor 5 polymorphisms in sarcoidosis
10. Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
11. Treatment with Methotrexate in Patients with Sarcoidosis
12. Differential effects of fosfomycin and corticosteroid on the molar ratio of interleukin-1 receptor antagonist/interleukin-1β in the culture supernatants of mononuclear phagocytes from patients with sarcoidosis
13. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups
14. Pharmacological Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
15. Diffuse Panbronchiolitis
16. Computed Tomography Analysis of Airway Dimensions and Lung Density in Patients with Sarcoidosis
17. Alveolar type II-like cells release G-CSF as neutrophil chemotactic activity
18. Bronchoalveolar Lavage in Idiopathic Interstitial Lung Diseases
19. Human lung fibroblasts release chemokinetic activity for monocytes constitutively
20. Clinical and Radiographic Indices Associated With Airflow Limitation in Patients With Sarcoidosis*
21. Incidence of Pulmonary Hypertension and Its Clinical Relevance In Patients with Idiopathic and Collagen Vascular Disease Associated Interstitial Pneumonias: O-6-3
22. Incidence of Pulmonary Hypertension and Its Clinical Relevance in Patients With Sarcoidosis*
23. Chymase Gene (CMA1) Polymorphisms in Dutch and Japanese Sarcoidosis Patients
24. Type II pneumocytes release chemoattractant activity for monocytes constitutively
25. Pulmonary Manifestations of Primary Sjögrenʼs Syndrome: A Clinical, Radiologic, and Pathologic Study
26. Cell Profiles of Bronchoalveolar Lavage Fluid as Prognosticators of Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia among Japanese Patients
27. Polymorphisms of B7 (CD80 and CD86) Genes Do Not Affect Disease Susceptibility to Sarcoidosis
28. The Clara Cell10 Adenine38Guanine Polymorphism and Sarcoidosis Susceptibility in Dutch and Japanese Subjects
29. Significance of lung shrinkage on CXR as a prognostic factor in patients with idiopathic pulmonary fibrosis
30. Decreased Level of Vascular Endothelial Growth Factor in Bronchoalveolar Lavage Fluid of Normal Smokers and Patients with Pulmonary Fibrosis
31. Dyspnea Is a Better Predictor of 5-Year Survival Than Airway Obstruction in Patients With COPD*
32. Serial Evaluation of High-Resolution Computed Tomography Findings in Patients with Idiopathic Pulmonary Fibrosis in Usual Interstitial Pneumonia
33. Change in Generic and Disease-Specific Health-Related Quality of Life during a One-Year Period in Patients with Newly Detected Chronic Obstructive Pulmonary Disease
34. Histamine stimulates alveolar macrophages to release neutrophil and monocyte chemotactic activity
35. Usual Interstitial Pneumonia: Idiopathic Pulmonary Fibrosis versus Collagen Vascular Diseases
36. Fibrogenic and Inflammatory Cytokines Modulate mRNA Expressions of Matrix Metalloproteinase-3 and Tissue Inhibitor of Metalloproteinase-3 in Type II Pneumocytes
37. Fibroblast Contractility: Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
38. Airway Wall Thickness in Asthma Assessed by Computed Tomography: Relation to Clinical Indices
39. The Effects of Oxitropium Bromide on Exercise Performance in Patients with Stable Chronic Obstructive Pulmonary Disease: A Comparison of Three Different Exercise Tests
40. Significance of the Interleukin-1 Receptor Antagonist/Interleukin-1β Ratio as a Prognostic Factor in Patients with Pulmonary Sarcoidosis
41. Airflow Limitation in Japanese Smokers: Significance of Serum Neutrophil Elastase/α1-Proteinase Inhibitor Ratio and FEV1 (%pred) Adjusted by Pack-Years
42. Bradykinin Stimulates Lung Fibroblasts to Release Neutrophil and Monocyte Chemotactic Activity
43. A Comparison of the Level of Dyspnea vs Disease Severity in Indicating the Health-Related Quality of Life of Patients With COPD*
44. A Novel, Short, and Simple Questionnaire to Measure Health-related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
45. Proinflammatory or Regulatory Cytokines Released from BALF Macrophages of Healthy Smokers
46. Comparison of the Bronchodilator Effects of Salbutamol Delivered via a Metered-Dose Inhaler with Spacer, a Dry-Powder Inhaler, and a Jet Nebulizer in Patients with Chronic Obstructive Pulmonary Disease
47. The Effect of High-Dose Inhaled Beclomethasone Dipropionate in Patients With Stable COPD*
48. Analysis of Clinical Methods Used to Evaluate Dyspnea in Patients with Chronic Obstructive Pulmonary Disease
49. Validation of the japanese version of the sarcoidosis health questionnaire: A cross-sectional study
50. Improvement of Survival in Patients with Diffuse Panbronchiolitis Treated with Low-dose Erythromycin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.